(88 days)
Not Found
No
The description focuses on the physical principles of OCT imaging and image construction based on light scattering, with no mention of AI or ML for image analysis or interpretation.
No
The device is described as an "imaging tool" for evaluating tissue microstructure, which implies diagnostic or observational use rather than treating or curing a medical condition.
No
The device is described as an "imaging tool" for visualizing tissue microstructure, but it does not state that it analyzes or interprets the images to provide a diagnosis or aid in diagnosis. Its function is to provide real-time visualization.
No
The device description explicitly states that the system consists of an "Imaging Console" and a "detachable, flexible fiberoptic Probe," which are hardware components.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use is described as an "imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization." This describes a device used to image within the body (in vivo) or directly on the surface of the body, not for testing samples outside the body (in vitro).
- Device Description: The description details how the device uses light to image tissue microstructure by analyzing backscattered light from within the tissue. This is consistent with an in vivo imaging modality like OCT.
- Anatomical Site: The anatomical site is "human tissue microstructure, tissue types such as skin and mucosal membranes," which are parts of the living body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (like blood, urine, tissue biopsies) outside of the body, which is a defining characteristic of IVDs.
Therefore, the Imalux OCT Imaging System is an in vivo imaging device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Imalux OCT (Optical Coherence Tomography) Imaging System is intended to be used as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization.
Product codes (comma separated list FDA assigned to the subject device)
IYO, NQQ
Device Description
The Imalux OCT (Optical Coherence Tomography) Imaging System utilizes near infrared (NIR) light to create high spatial resolution, real-time images near infrared (1127) be Imalux OCT Imaging System consists of an Imaging Console and a detachable, flexible fiberoptic Probe. The Imaging Console Console and a detailsptical and electrical components and a user interface system. The user interface system includes a keyboard, display, and standard Ethernet and USB ports for image data transfer.
As various tissue structural elements absorb, reflect, and scatter light As various NIR light that is backscattered from the tissue is collected and analyzed to present an image of the tissue microstructure. By analyzing andly200 to probesity as a function of tissue depth, over a lateral surface, a 2-dimensional image is constructed.
At any one lateral position, the in-depth OCT image is analogous to an At any one accrar presents backscattering intensity as a function of depth. By combining the in-depth scanning with lateral movement of the depth. Dy connemional image is created that is analogous to that of ultrasound B-scan, except that OCT uses light in lieu of sound waves. By using light instead of sound, the Imalux OCT Imaging System can achieve higher spatial resolution, but to a more shallow imaging depth, than ultrasound imaging since light is more readily attenuated in the tissue.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Optical Coherence Tomography (OCT)
Anatomical Site
human tissue microstructure, tissue types such as skin and mucosal membranes.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
To assure the safety of the device, the System has been tested to and complies with the standards listed below:
EN / IEC 60601-1
EN / IEC 60601-1-2
EN / IEC 60825-1
AAMI / ANSI / ISO 10993-1
AAMI / ANSI ST35
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
510(k) SUMMARY
This summary is being submitted in accordance with 21 CFR 807.92.
Submitter's name, address, telephone number, initial importer, contact person A.
| Submitter's Name: | Imalux Corporation |
|---|---|
| Address: | 1771 East 30th Street |
| Address: | Cleveland, OH 44114 |
| Official Contact: | Stephanie A. S. Harrington |
| Title: | Vice President, Regulatory & Clinical Affairs |
| Telephone: | 216 502-0755 |
| Fax: | 216 622-0723 |
| E-mail: | harrington@imalux.com |
Device Name, Common Name B.
1. Common/Usual Name
Optical Coherence Tomography Scanner
2. Device Name
Imalux OCT Imaging System
3. Classification Name
| Name | Classification
Regulation | Product Code | Class |
|------------------------------------------|------------------------------|--------------|-------|
| Ultrasonic pulsed echo
imaging system | 892.1560 | IYO | II |
Identification of the predicate or legally marketed device C.
| Device Name | 510(k) Number |
|---|---|
| Humphrey Optical Coherence Tomography (OCT) | |
| Scanner | K944523 |
1
Device Description D.
1. Summary
The Imalux OCT (Optical Coherence Tomography) Imaging System utilizes near infrared (NIR) light to create high spatial resolution, real-time images near infrared (1127) be Imalux OCT Imaging System consists of an Imaging Console and a detachable, flexible fiberoptic Probe. The Imaging Console Console and a detailsptical and electrical components and a user interface system. The user interface system includes a keyboard, display, and standard Ethernet and USB ports for image data transfer.
As various tissue structural elements absorb, reflect, and scatter light As various NIR light that is backscattered from the tissue is collected and analyzed to present an image of the tissue microstructure. By analyzing andly200 to probesity as a function of tissue depth, over a lateral surface, a 2-dimensional image is constructed.
At any one lateral position, the in-depth OCT image is analogous to an At any one accrar presents backscattering intensity as a function of depth. By combining the in-depth scanning with lateral movement of the depth. Dy connemional image is created that is analogous to that of ultrasound B-scan, except that OCT uses light in lieu of sound waves. By using light instead of sound, the Imalux OCT Imaging System can achieve higher spatial resolution, but to a more shallow imaging depth, than ultrasound imaging since light is more readily attenuated in the tissue.
Design 2.
The Scanner contains optical and electrical components, including a super luminescent diode (SLD) light source. The NIR light is directed from the Scanner through the Probe's optical fiber to the patient's tissue. The optical light is backscattered from the patient's tissue, collected by the Probe's fiber, and, combined with an internal reference signal, to produce a high spatial resolution image of the superficial tissue microstructure. By using a spatial lateral scanning mechanism contained within the probe, the optical Strain scans laterally across the tissue surface while simultaneously acquiring an in-depth profile at each lateral position. By combining inacquiring an in-depth profits at cash internet System produces a two-dimensional cross-sectional image of the tissue microstructure.
The Imaging Console has a user interface for acquiring, displaying, and reporting images. Image data is stored onto the system and can be exported via Ethernet or USB data ports on the console.
2
3. Materials
The external materials of the Probe distal tip are commonly used medical device materials and have been evaluated for biocompatibility. This evaluation, supported with biocompatibility testing, has demonstrated that these materials are safe for the Probe's intended use.
Intended Use E.
The Imalux OCT (Optical Coherence Tomography) Imaging System is intended to be used as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time denth visualization.
While the Humphrey's indication is for ocular use, imaging of sensitive eye tissue, the Imalux OCT Imaging System is indicated for use on tissue types such as skin and mucosal membranes. While the indications are different, the indications for the Imalux OCT device and the Humphrey OCT device are both within the same intended use and a comparison of their respective technologies and functional characteristics shows that the Imalux device is at least as safe and effective as the Humphrey device for this intended use.
Safety & Performance F.
To assure the safety of the device, the System has been tested to and complies with the standards listed below:
EN / IEC 60601-1 EN / IEC 60601-1-2 EN / IEC 60825-1 AAMI / ANSI / ISO 10993-1 AAMI / ANSI ST35
The Imalux OCT Imaging System is substantially equivalent to the Humphrey OCT Scanner as both devices employ the same technology, Optical Coherence Tomography, and have the same intended use of revealing tissue structural information by providing two-dimensional, crosssectional, real-time depth visualization.
Both the Imalux OCT Imaging System and the Humphrey OCT Scanner employ NIR light that is transported through a fiberoptic connection. The Imalux device uses a detachable, fiberoptic Probe that facilitates the transport of NIR light between the Imaging Console and the patient tissue; whereas, the Humphrey OCT Scanner has a fiberoptic imaging head that is connected to the console. By using a detachable, fiberoptic Probe, the
3
Imalux device can acquire images from different target tissues and facilitate reprocessing; whereas, the Humphrey device requires that the patient be positioned in close proximity to the imaging head, a design which is compatible for the device's indication for scanning ocular tissue. The Imalux device permits tissue image sampling, consistent with its indication for use, while employing the same fundamental OCT technological characteristics.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR - 1 2004
Ms. Stephanie A.S. Harrington Vice President, Regulatory and Clinical Affairs Imalux Corporation 1771 East 30th Street Cleveland, Ohio 44114
Rc: K033783
Trade/Device Name: Imalux OCT Imaging System Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: II Product Code: NQQ Dated: December 3, 2003 Received: December 4, 2003
Dear Ms. Harrington:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your becamed the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate 101 use stated in the eneksbare) to the enactment date of the Medical Device Amendments, or to commerce price to May 20, 1978, the excordance with the provisions of the Federal Food, DINAA de vices that have been require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The r ou may, mercere, market the act include requirements for annual registration, listing of general controls provisions of vactice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it 11 your device ts clashinod (600 a00 royols. Existing major regulations affecting your device can may be subject to such additional controller Lifting - Parts 800 to 898. In addition, I'DA may be found in are be obserning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination docs not mean Ficase oe advised that 1171 5 issualite or our device complies with other requirements of the Act that I DA has made a determinations administered by other Federal agencies. You must or any I coleral statutes and regalations and limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set CI'N I at 607), adomig (21 OF N Part 820), and if applicable, the elcottonic forth in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050.
5
Page 2 - Ms. Stephanie A.S. Harrington
This letter will allow you to begin marketing your device as described in your Section 510(k) I ms lotter will and in your he FDA finding of substantial equivalence of your device to a legally prematical predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please it you active of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to promarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small other general international and Consumer Assistance at its toll-frec number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
Sincerely yours,
Mark A. Millenson
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
INDICATIONS FOR USE 4
K033783 510(k) Number (if known):
Device Name:
Imalux OCT Imaging System
Indications For Use:
The Imalux OCT (Optical Coherence Tomography) Imaging System is The Imatux OUT (Option of in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization.
AND/OR Prescription Use _ V (Part 21 CFR 801 Subpart D)
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| -- | -------------------------------------------- |
for (Division Sign-Off)
Division of General, Restorative,
and Neurological Devices
| 510(k) Number | K033783 |
|---|---|
| --------------- | --------- |